Amino acid antagonists do not block the depolarizing effects of potassium ions on frog primary afferents.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 6768000)

Published in Neuroscience on January 01, 1980

Authors

R A Davidoff, J C Hackman, I Osorio

Articles by these authors

Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology (1998) 2.32

Inhibitory of glycine on spinal neurons in the cat. J Neurophysiol (1968) 2.17

Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia (2000) 2.02

Inhibition of motoneurones by iontophoresis of glycine. Nature (1967) 1.65

Antispasticity drugs: mechanisms of action. Ann Neurol (1985) 1.48

Gamma-aminobutyric acid antagonism and presynaptic inhibition in the frog spinal cord. Science (1972) 1.42

The effects of strychnine on the inhibition of interneurons by glycine and gamma-aminobutyric acid. Int J Neuropharmacol (1969) 1.30

Association of glycine with spinal interneurones. Nature (1967) 1.27

The effects of Lioresal on synaptic activity in the isolated spinal cord. Neurology (1974) 1.25

Dacrystic epilepsy. J Neurol Neurosurg Psychiatry (1976) 1.16

The effects of bicuculline on the isolated spinal cord of the frog. Exp Neurol (1972) 1.15

A comparison of the concentration of glycine, a transmitter suspect, in different areas of the brain and spinal cord in seven different vertebrates. Comp Biochem Physiol (1969) 1.13

Changes in amino acid concentrations associated with loss of spinal interneurons. J Neurochem (1967) 1.07

Pharmacology of spasticity. Neurology (1978) 1.04

High affinity amino acid transport by frog spinal cord slices. J Neurochem (1975) 1.02

Activity of respiratory neurons during NREM sleep. J Neurophysiol (1985) 1.01

Picrotoxin antagonism of the inhibition of interneurons by glycine. Life Sci (1969) 0.99

Network system for automated seizure detection and contingent delivery of therapy. J Clin Neurophysiol (2001) 0.97

Phenytoin-induced ophthalmoplegia. Neurology (1976) 0.94

Penicillin and presynaptic inhibition in the amphibian spinal cord. Brain Res (1972) 0.92

Left vagus nerve stimulation with the neurocybernetic prosthesis has complex effects on heart rate and on its variability in humans. Epilepsia (2001) 0.90

Pharmacologically novel GABA receptor in human dorsal root ganglion neurons. J Neurophysiol (1996) 0.89

GABA-Induced Cl- current in cultured embryonic human dorsal root ganglion neurons. J Neurophysiol (1999) 0.89

Electrical and thermal behavior of non-ferrous noble metal electrodes exposed to MRI fields. Magn Reson Imaging (2002) 0.85

The characteristics and mechanisms of visual disturbance associated with anticonvulsant therapy. Neurology (1990) 0.85

Stochastic modeling and prediction of experimental seizures in Sprague-Dawley rats. J Clin Neurophysiol (2001) 0.84

Spectrum of clinical and histopathologic responses to intracranial electrodes: from multifocal aseptic meningitis to multifocal hypersensitivity-type meningovasculitis. Epilepsia (2001) 0.84

Alcohol and presynaptic inhibition in an isolated spinal cord preparation. Arch Neurol (1973) 0.83

Hyperpolarization of frog primary afferent fibres caused by activation of a sodium pump. J Physiol (1980) 0.83

Changes in membrane potential of frog motoneurons induced by activation of serotonin receptor subtypes. Neuroscience (1990) 0.83

Penicillin and inhibition in the cat spinal cord. Brain Res (1972) 0.83

Absence of REM and altered NREM sleep in patients with spinocerebellar degeneration and slow saccades. Ann Neurol (1980) 0.83

Serotonin1A facilitation of frog motoneuron responses to afferent stimuli and to N-methyl-D-aspartate. Neuroscience (1992) 0.82

The inhibitory action of cystathionine. Life Sci (1966) 0.82

Optokinetic nystagmus and cerebral disease; clinical and pathological study. Arch Neurol (1966) 0.81

The roles of semantic networks and search efficiency in verbal fluency performance in intractable temporal lobe epilepsy. Epilepsy Res (1995) 0.81

GABA and glycine transport in frog CNS: high affinity uptake and potassium-evoked release in vitro. Brain Res (1976) 0.81

Spinal seizures and excitatory amino acid-mediated synaptic transmission. Neurosci Lett (1984) 0.80

Mechanisms involved in the metabotropic glutamate receptor-enhancement of NMDA-mediated motoneurone responses in frog spinal cord. Br J Pharmacol (1999) 0.80

Activation of 5-HT1C/2 receptors depresses polysynaptic reflexes and excitatory amino acid-induced motoneuron responses in frog spinal cord. Brain Res (1992) 0.79

Potential changes of frog afferent terminals in response to dopamine. Brain Res (1985) 0.79

Pentylenetetrazol and reflex activity of isolated frog spinal cord. Neurology (1978) 0.79

Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex. Neurosci Lett (1995) 0.79

Effects of synthetic buffers on reflexes in the isolated frog spinal cord. Am J Physiol (1975) 0.79

Spontaneous dorsal root potentials arise from interneuronal activity in the isolated frog spinal cord. Brain Res (1984) 0.79

Epileptic gaze deviation and nystagmus. Neurology (1985) 0.78

N-methyl bicuculline and primary afferent depolarization. Exp Neurol (1973) 0.78

Excitatory amino acids and potassium release in the frog spinal cord. Neurosci Lett (1982) 0.78

GABA 'desensitization' of frog primary afferent fibers. Brain Res (1982) 0.78

Primary afferent activity, putative excitatory transmitters and extracellular potassium levels in frog spinal cord. J Physiol (1988) 0.78

Serotonin and GABA-induced depolarizations of frog primary afferent fibers. Brain Res (1990) 0.78

Pentobarbital-activated Cl(-) channels in cultured adult and embryonic human DRG neurons. Brain Res Dev Brain Res (2000) 0.78

Changes in motoneuron membrane potential and reflex activity induced by sudden cooling of isolated spinal cords: differences among cold-sensitive, cold-resistant and freeze-tolerant amphibian species. J Exp Biol (1995) 0.77

Modulation of frog spinal cord interneuronal activity by activation of 5-HT3 receptors. Brain Res (1995) 0.77

Cerebral venous thrombosis in paroxysmal nocturnal hemoglobinuria: report of two cases. Neurology (1993) 0.77

High-affinity uptake of (3H)gamma-aminobutyric acid into frog spinal cord slices. Brain Res (1974) 0.77

Antiepileptic drug intoxication: factors and their significance. Epilepsia (1991) 0.77

Dorsal root potentials in the isolated frog spinal cord: amino acid neurotransmitters and magnesium ions. Neuroscience (1991) 0.76

Childhood caffeine tic syndrome. Pediatrics (1998) 0.76

Studies of the uptake and release of [3H]beta-alanine by frog spinal slices. J Neurochem (1977) 0.76

After-hyperpolarizations produced in frog motoneurons by excitatory amino acid analogues. Brain Res (1987) 0.76

Activation of alpha-adrenoceptors indirectly facilitates sodium pumping in frog motoneurons. Brain Res (1993) 0.76

Aspects of spinal cord structure and reflex function. Neurol Clin (1991) 0.76

Epinephrine and norepinephrine modulate neuronal responses to excitatory amino acids and agonists in frog spinal cord. Synapse (1987) 0.76

The effects of microelectrophoretically applied thyroid hormone on single cat central nervous system neurons. Neurology (1972) 0.76

An in vitro study of the effects of serotonin on frog primary afferent terminals. Neurosci Lett (1990) 0.76

Refractory idiopathic status epilepticus. Epilepsia (2001) 0.75

Analysis of the responses of frog motoneurons to epinephrine and norepinephrine. Neurosci Lett (1986) 0.75

gamma-Hydroxybutyric acid is not a GABA-mimetic agent in the spinal cord. Ann Neurol (1979) 0.75

Excitatory transmitters, ventral root potentials and [K+]o in the isolated frog leg-spinal cord preparation. Neurosci Lett (1988) 0.75

On headache and the neck. Cephalalgia (1999) 0.75

The function of dreaming. Neurology (1984) 0.75

Valproic acid loading during intensive monitoring. Arch Neurol (1988) 0.75

Vagal and sciatic nerve stimulation have complex, time-dependent effects on chemically-induced seizures: a controlled study. Brain Res (2001) 0.75

Phenobarbital for status epilepticus. Neurology (1988) 0.75